First-of-its-kind study indicates pretreatment improves outcomes over standard-of-care surgery Watch to learn more about the trial results from Dr. Amaria HOUSTON – A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at The University of Texas MD Anderson Cancer Center report in Lancet Oncology. Patients who had no sign of disease at surgery after […]
